Last updated: November 26, 2024
Sponsor: District Headquarters Teaching Hospital Sahiwal
Overall Status: Completed
Phase
2/3
Condition
Hemorrhage
Allergies & Asthma
Dysfunctional Uterine Bleeding
Treatment
Tranexamic Acid
Calcium dobesilate (Doxium)
Clinical Study ID
NCT06707051
2096
DHQTHS
Ages 18-40 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Women of 18-40 years
Abnormal uterine bleeding
Exclusion
Exclusion Criteria:
Patients with pregnancy
Miscarriage
Hypersensitivity to pharmacological agents to be used in trial
Patients having moderate to severe anemia (Hb:<8gm/dl)
Patients with thyroid abnormalities (TSH > 5mIU)
Benign uterine conditions e.g. fibroid uterus, endometrial/cervical polyp
Uterine malignancy
Coagulation disorders (PT : >15sec).
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Tranexamic Acid
Phase: 2/3
Study Start date:
January 01, 2022
Estimated Completion Date:
June 30, 2024
Study Description
Connect with a study center
Sahiwal teaching Hospital Sahiwal
Sahiwal, Punjab 57000
PakistanSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.